Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 9, 2010, Pages 1303-1311

  Kalimutho, Murugan ^a   Blanco, Giovanna Del Vecchio ^b   Gravina, Paolo ^b   Cretella, Micaela ^b   Mannucci, Liliana ^b   Mannisi, Elena ^b   Formosa, Amanda ^a   Pallone, Francesco ^b   Federici, Giorgio ^a,b   Bernardini, Sergio ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

adenomatosis polyposis coli (APC); colorectal cancer; denaturing HPLC; faecal DNA; faeces; quantitative

Indexed keywords

BETA ACTIN; DNA; GLUTAMIC ACID; LYSINE;

ADENOMATOSIS POLYPOSIS COLI; ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL ASSESSMENT; CODON; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DNA DETERMINATION; FECES; FEMALE; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ACTINS; ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; AGED, 80 AND OVER; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; DNA; DNA MUTATIONAL ANALYSIS; FEASIBILITY STUDIES; FECES; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; MIDDLE AGED; NUCLEIC ACID DENATURATION; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77957299914     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.245     Document Type: Article

References (43)

1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71. (Pubitemid 23131388)
2. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997;47:154-60.
3. Markowitz AJ, Winawer SJ. Screening and surveillance for colorectal cancer. Semin Oncol 1999;26:485-98.
4. Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001;93:858-65. (Pubitemid 32586613)
5. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-41. (Pubitemid 23098782)
6. Calvert PM, Frucht H. The genetic of colorectal cancer. Ann Intern Med 2002:137: 603-12.
7. Boynton KA, Summerhayes IA, Ahlquist DA, Shuber AP. DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem 2003;49:1058-65. (Pubitemid 36751091)
8. Ahlquist DA, Skoletsk JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219-27.
9. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102-5.
10. Nollau P, Moser C, Weinland G, Wagener C. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant enriched PCR. Int J Cancer 1996;66:332-6. (Pubitemid 26163607)
11. Smith-Ravin J, England J, Talbot IC, Bodmer W. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 1995;36:81-6.
12. Deuter R, Muller O. Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR. Hum Mutat 1998;11:84-9. (Pubitemid 128679154)
13. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60. (Pubitemid 351830299)
14. Hongzhi Z, Harrington JJ, Klatt KK, Ahquist DA. A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2006;15:1115-9.
15. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192-206. (Pubitemid 40039970)
16. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002;346:311-20. (Pubitemid 34438838)
17. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, et al. APC mutations in sporadic colorectal tumors: a mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA 2000;97:3352-7. (Pubitemid 30183306)
18. Haug U, Hillebrand T, Bendzko P, Low M, Rothenbacher D, Stegmaier C, et al. Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults. Clin Chem 2007;53:787-90. (Pubitemid 46580254)
19. Diehl F, Li M, Dressman D, He Y, Shen D, Diaz LA, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 2005;102:16368-73. (Pubitemid 41688920)
20. Zou H, Taylor WR, Harrington JJ, Hussain Ft, Cao X, Loprinzi CL. et al. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology 2009;136:459-70.
21. Cotton RGH. Slowly but surely towards better scanning for mutations. Trends Genet 1997;13:43-6.
22. Sivakumaran TA, Kucheria K, Oefner PJ. Denaturing high performance liquid chromatography in the molecular diagnosis of genetic disorders. Curr Sci 2003;84:291-6. (Pubitemid 39174833)
23. O'Donovan MC, Oefner PJ, Roberts SC, Austin J, Hoogendoorn B, Guy C, et al. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 1998;52:44-9. (Pubitemid 28452169)
24. Arnold N, Gross E, Schwarz-Boeger U, Pfisterer J, Jonat W, Kiechle MA. Highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum Mutat 1999;14:333-9. (Pubitemid 29480318)
25. Hoogendoorn B, Norton N, Kirov G, Williams N, Hamshere ML, Spurlock G, et al. Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Hum Genet 2000;107:488-93. (Pubitemid 32000419)
26. Spiegelman JI, Mindrinos MN, Oefner PJ. High-accuracy DNA sequence variation screening by DHPLC. Biotechniques 2000;29:1084-90.
27. Roberts PS, Jozwiak S, Kwiatkowski DJ, Dabora SL. Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene. J Biochem Biophys Methods 2001;47:33-7. (Pubitemid 32155473)
28. Taliani MR, Roberts SC, Dukek BA, Pruthi RK, Nichols WL, Heit JA. Sensitivity and specificity of denaturing high-pressure liquid chromatography for unknown protein C gene mutations. Genet Test 2001;5:39-44.
29. Xiao W, Oefner PJ. Denaturing high performance liquid chromatography: a review. Hum Mutat 2001;17:439-74. (Pubitemid 32480082)
30. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening of colorectal cancer in adults at average risk: a summary of the evidence for the U. S. Preventive Service Task Force. Ann Intern Med 2002;137:132-41. (Pubitemid 34779159)
31. Kristinsson J, Nygaard K, Aadland E, Barstad S, Sauar J, Hofstad B, et al. Screeening of the first degree relatives of patients operated for corlorectal cancer: evaluation of faecal calprotectin vs. hemoccult II. Digestion 2001;64:104-10. (Pubitemid 34701878)
32. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, et al. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol 2008;103:2862-70.
33. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14. (Pubitemid 39665324)
34. Lai LP, Su YN, Hsieh FJ, Chiang FT, Juang JM. Liu YB, et al. Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms. J Hum Genet 2005;50:490-6.
35. Van den Bosch BJC, De Coo RFM, Scholte HR, Nijland JG, Van Den Bogaard R, De Visser M, et al. Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res 2000;28:81-9.
36. Wolford JK, Blunt D, Ballecer C, Prochazka M. Highthroughput SNP detection by using DNA pooling and denaturing high performance liquid chromatography (DHPLC). Hum Genet 2000:107: 483-7. (Pubitemid 32000418)
37. Kwok PY, Deng Q, Zakeri H, Taylor SL, Nickerson DA. Increasing the information content of STS-based genome maps: identifying polymorphisms in mapped STSs. Genomics 1996;31:123-6. (Pubitemid 26044763)
38. Tibble J, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal neoplasia. Gut 2001;49:402-8. (Pubitemid 32802576)
39. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC, Sontag S, et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007;5:111-7. (Pubitemid 46096834)
40. Syngal S, Stotfel E, Chung D, Willwtt C, Schoetz D, Schroy P, et al. Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer 2006;106:277-83. (Pubitemid 43100434)
41. Kutzner N, Hoffmann I, Linke C, Thienel T, Grzegorczyk M, Urfer W, et al. Non-invasive detection of colorectal tumors by the combined application of molecular and diagnosis and the faecal occult blood test. Cancer letter 2005;229:33-41. (Pubitemid 41262537)
42. Calistri D, Rengucci C, Lattunrddu A, Francioni G, Polifemo AM, Nanni O, et al. Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool. Neoplasia 2004;6:536-40. (Pubitemid 39411090)
43. Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H, Uchida T, et al. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009;101:1244-58.